000 01303 a2200397 4500
005 20250513055822.0
264 0 _c19940906
008 199409s 0 0 eng d
022 _a0022-5347
024 7 _a10.1016/s0022-5347(17)32587-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEllerhorst, J A
245 0 0 _aPhase II trial of low dose gamma-interferon in metastatic renal cell carcinoma.
_h[electronic resource]
260 _bThe Journal of urology
_cSep 1994
300 _a841-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCarcinoma, Renal Cell
_xtherapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aInterferon-gamma
_xadministration & dosage
650 0 4 _aKidney Neoplasms
_xtherapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
700 1 _aKilbourn, R G
700 1 _aAmato, R J
700 1 _aZukiwski, A A
700 1 _aJones, E
700 1 _aLogothetis, C J
773 0 _tThe Journal of urology
_gvol. 152
_gno. 3
_gp. 841-5
856 4 0 _uhttps://doi.org/10.1016/s0022-5347(17)32587-9
_zAvailable from publisher's website
999 _c8051060
_d8051060